The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Psychological Tests

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Psychological Tests


Psychiatry related information on Psychological Tests


High impact information on Psychological Tests


Chemical compound and disease context of Psychological Tests

  • Methylphenidate was instrumental in improving performance on many psychological tests, but did not affect performance on standardized achievement tests [15].
  • The effects of diazepam (0.2 mg/kg for 15 days followed by 0.3 mg/kg for 7 days), oxazepam (0.8 mg/kg for 15 days followed by 1.2 mg/kg for 7 days), and placebo were studied in healthy subjects after the first dose, once a week during chronic dosing, and at 48 and 96 hours after withdrawal through a battery of psychologic tests [16].
  • The results of psychologic tests reflecting visual-spatial planning were significantly better for the four children receiving CS with lower IQ scores (87 to 105) but not for the nine children with higher IQ scores (111 to 134) [17].
  • Finger tremor increased, and some psychologic tests were impaired by thioridazine; other psychologic tests, the auditory-evoked response, and palmar skin conductance were unaffected and showed no relationship to drug or prolactin levels [18].
  • Some patients showed improvements (greater than 20%) in peak expiratory flow, FEV1 or forced vital capacity (FVC) after prednisolone, but nearly all had improvements in at least one psychological test [19].

Biological context of Psychological Tests


Anatomical context of Psychological Tests


Gene context of Psychological Tests


Analytical, diagnostic and therapeutic context of Psychological Tests


  1. Psychological factors associated with primary fibromyalgia syndrome. Ahles, T.A., Yunus, M.B., Riley, S.D., Bradley, J.M., Masi, A.T. Arthritis Rheum. (1984) [Pubmed]
  2. Serum androgens and depression in women with facial hirsutism. Shulman, L.H., DeRogatis, L., Spielvogel, R., Miller, J.L., Rose, L.I. J. Am. Acad. Dermatol. (1992) [Pubmed]
  3. Sequential psychological testing during the course of autoimmune hyperthyroidism. Paschke, R., Harsch, I., Schlote, B., Vardarli, I., Schaaf, L., Kaumeier, S., Teuber, J., Usadel, K.H. Klin. Wochenschr. (1990) [Pubmed]
  4. Mathematical models of cognitive recovery. Wong, P.P., Monette, G., Weiner, N.I. Brain injury : [BI]. (2001) [Pubmed]
  5. Interaction between constant levels of low back pain and other psychological parameters. Líndal, E. Psychological reports. (1990) [Pubmed]
  6. Effect of cyclandelate on dementia. Westreich, G., Alter, M., Lundgren, S. Stroke (1975) [Pubmed]
  7. Psychopharmacological effects of pyritinol in normal volunteers. Hindmarch, I., Coleston, D.M., Kerr, J.S. Neuropsychobiology (1990) [Pubmed]
  8. Psychological studies in dystonia musculorum deformans. Riklan, M., Cullinan, T., Cooper, I.S. Advances in neurology. (1976) [Pubmed]
  9. Partnership in transsexualism. Part I. Paired and nonpaired groups. Huxley, P.J., Kenna, J.C., Brandon, S. Archives of sexual behavior. (1981) [Pubmed]
  10. Relationships between personality traits, seminal parameters and hormones in male infertility. Conrad, R., Schilling, G., Haidl, G., Geiser, F., Imbierowicz, K., Liedtke, R. Andrologia (2002) [Pubmed]
  11. Methylphenidate hydrochloride effects on psychological tests in acute schizophrenic and nonpsychotic patients. Janowsky, D.S., Huey, L., Storms, L., Judd, L.L. Arch. Gen. Psychiatry (1977) [Pubmed]
  12. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Kozora, E., Thompson, L.L., West, S.G., Kotzin, B.L. Arthritis Rheum. (1996) [Pubmed]
  13. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Liang, M.H., Rogers, M., Larson, M., Eaton, H.M., Murawski, B.J., Taylor, J.E., Swafford, J., Schur, P.H. Arthritis Rheum. (1984) [Pubmed]
  14. Diagnosis and clinical assessment: current status and major issues. McReynolds, P. Annual review of psychology. (1989) [Pubmed]
  15. Methylphenidate effects in learning disabilities. Psychometric changes. Gittleman-Klein, R., Klein, D.F. Arch. Gen. Psychiatry (1976) [Pubmed]
  16. Comparison of two benzodiazepines with differing accumulation: behavioral changes during and after 3 weeks of dosing. Ghoneim, M.M., Hinrichs, J.V., Mewaldt, S.P. Clin. Pharmacol. Ther. (1986) [Pubmed]
  17. Clinical, physiologic, and psychologic comparison of treatment by cromolyn or theophylline in childhood asthma. Springer, C., Goldenberg, B., Ben Dov, I., Godfrey, S. J. Allergy Clin. Immunol. (1985) [Pubmed]
  18. Prolactin and psychophysiologic measures after single doses of thioridazine. Nikitopoulou, G., Thorner, M., Crammer, J., Lader, M. Clin. Pharmacol. Ther. (1977) [Pubmed]
  19. Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment. Mitchell, D.M., Gildeh, P., Rehahn, M., Dimond, A., Collins, J.V. Thorax (1984) [Pubmed]
  20. Emotional status does not alter exercise tolerance in patients with chronic obstructive pulmonary disease. Borak, J., Chodosowska, E., Matuszewski, A., Zielinski, J. Eur. Respir. J. (1998) [Pubmed]
  21. Toxicological and neuropsychological findings in patients presenting to an environmental toxicology service. Köppel, C., Fahron, G. J. Toxicol. Clin. Toxicol. (1995) [Pubmed]
  22. Visually evoked potentials and simple reaction times to visual stimuli in chronic disulphide intoxication. Sikora, A., Langauer-Lewowicka, H., Kazibutowska, Z. Polish journal of occupational medicine. (1990) [Pubmed]
  23. Labor experience, maternal mood and cortisol and catecholamine levels in low-risk primiparous women. Mahomed, K., Gülmezoglu, A.M., Nikodem, V.C., Wolman, W.L., Chalmers, B.E., Hofmeyr, G.J. Journal of psychosomatic obstetrics and gynaecology. (1995) [Pubmed]
  24. Combined atropine and 2-PAM Cl effects on tracking performance and visual, physiological, and psychological functions. Penetar, D.M., Haegerstrom-Portnoy, G., Jones, R.T. Aviation, space, and environmental medicine. (1988) [Pubmed]
  25. Neuropeptide Y plasma levels and immunological changes during academic stress. Guidi, L., Tricerri, A., Vangeli, M., Frasca, D., Riccardo Errani, A., Di Giovanni, A., Antico, L., Menini, E., Sciamanna, V., Magnavita, N., Doria, G., Bartoloni, C. Neuropsychobiology (1999) [Pubmed]
  26. A pilot study of neuropsychological function in girls with ADHD. Seidman, L.J., Biederman, J., Faraone, S.V., Weber, W., Mennin, D., Jones, J. Journal of the American Academy of Child and Adolescent Psychiatry. (1997) [Pubmed]
  27. The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Subhan, Z., Hindmarch, I. International journal of clinical pharmacology research. (1984) [Pubmed]
  28. A repressive coping style protecting from emotional distress in low-renin essential hypertensives. Perini, C., Smith, D.H., Neutel, J.M., Smith, M.A., Henry, J.P., Bühler, F.R., Weiner, H., Weber, M.A. J. Hypertens. (1994) [Pubmed]
  29. Spatio-temporal disintegration of visual perception in schizophrenia as revealed by a novel cognitive task, the Searchlight Test. Izawa, R., Yamamoto, S. Schizophr. Res. (2002) [Pubmed]
  30. New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Otaka, M., Jin, M., Odashima, M., Matsuhashi, T., Wada, I., Horikawa, Y., Komatsu, K., Ohba, R., Oyake, J., Hatakeyama, N., Watanabe, S. Aliment. Pharmacol. Ther. (2005) [Pubmed]
  31. NGF and the treatment of Alzheimer's disease. Olson, L. Exp. Neurol. (1993) [Pubmed]
  32. A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects. Yu, G., Maskray, V., Jackson, S.H., Swift, C.G., Tiplady, B. British journal of clinical pharmacology. (1991) [Pubmed]
  33. Central nervous system side effects of beta-adrenergic blocking agents with high and low lipid solubility. Conant, J., Engler, R., Janowsky, D., Maisel, A., Gilpin, E., LeWinter, M. J. Cardiovasc. Pharmacol. (1989) [Pubmed]
  34. Safety and efficacy of human growth hormone treatment in girls with Turner syndrome. Price, D.A., Clayton, P.E., Crowne, E.H., Roberts, C.R. Horm. Res. (1993) [Pubmed]
  35. Methaqualone abusers: a preliminary survey of college students. Kochansky, G.E., Hemenway, T.S., Salzman, C., Shader, R.I. Diseases of the nervous system. (1975) [Pubmed]
WikiGenes - Universities